There is an evident space between foot-care knowledge and methods which should be addressed through comprehensive behaviour modification techniques. Comprehensive risk-assessments for diabetes associated complications needs to be piloted at community degree to assess the feasibility.There clearly was an obvious gap between foot-care knowledge and techniques that should be dealt with through extensive behaviour modification methods. Comprehensive risk-assessments for diabetic issues linked problems has to be piloted at neighborhood level to evaluate the feasibility.Achieving adequate glycemic control in type 2 diabetes mellitus (T2DM) remains a challenging but achievable goal. Oral agents (OADs) are essential selection for handling of T2DM. Many T2DM customers need more than one medicine for adequate glycemic control. Metformin based combination therapy is advised when monotherapy is inadequate. Evogliptin is a recently created dipeptidyl peptidase-4 (DPP-4) inhibitor, which can is coupled with metformin for the treatment of T2DM. Blend treatment of Evogliptin and Metformin reduces blood sugar via enlargement of insulin secretion, suppression of glucagon secretion, and insulin sensitization. Co-administration of Evogliptin and Metformin revealed no clinically appropriate pharmacokinetic differences compared to the administration of each and every drug alone. Mix treatment of Evogliptin and Metformin additionally provides substantially much better glycemic control compared towards the respective monotherapies. Effectiveness and safety of Evogliptin and Metformin was in fact demonstrated in many multicentre randomized clinical trials carried out in a variety of countries like South Korea, Russia and Asia. Consequently, fixed dose combination (FDC) of Evogliptin and Metformin is authorized in South Korea and India. Complexity associated with therapy regime and polypharmacy are popular aspects of poor medication adherence and FDCs possess potential to improve micrornamimics adherence by reducing the pill burden. Use with this combo therapy in clinical rehearse for handling of T2DMs offer a greater amount of HbA1c reduction than that seen with the use of either medicine as monotherapy, and is not likely resulting in significant hypoglycemia. Blend treatment of Evogliptin and Metformin is a promising strategy when you look at the treatment of T2DM. Workout prescription has become a mandatory yet exceedingly under ranked non-pharmacological approach in management generally of diabetes mellitus. SMART acronym for S – specific, M – measurable, A – attainable, R – practical, T – time focused, is a newly suggested idea for implementing similar with supposedly better results. We tried to analyse the results objectively by SMART prescription of individualized exercise regimes to clients along with medicines. Single centred, potential research performed over an occasion span of 3 months, on 75 customers, with biweekly followup. At the conclusion of three months, we evaluated the results (of 52 clients whom remained) by evaluating random blood glucose and glycosylated haemoglobin values associated with the patients at the start and end regarding the test. A substantial decrease in blood glucose (p-0.023) and A1C amounts (p-0.105; ns) had been mentioned after a period of 90 days; with the average reduction of 31mg/ dl and 0.37% noted in each respectively. Additional benefits of better follow up, decreased financial burden, increased compliance to the said routine were seen. Promoting exercise and life style changes can be as crucial as pharmacological management in diabetes. A GOOD method, methodical prescription regarding the workouts and medicines- individualized for patients, will likely have better results and diligent satisfaction. A practice of switching to precise written suggestions than spoken tips and reviewing the development on every follow through visit may enhance the outcome.Recommending exercise and change in lifestyle can be as essential as pharmacological management in diabetes. A SMART approach, methodical prescription for the exercise sessions and medicines- individualized for patients, will probably have better results and diligent satisfaction. A practice of switching to precise written recommendations than spoken ideas and reviewing the progress on every follow up visit may enhance the outcome. In SARS-CoV2 illness multi-organ involvement of heart, kidney pancreas and liver tend to be reported. Most researches suggest that though moderate derangements of liver function may be experienced by most COVID-19 clients but significant liver damage is not common. The goal of this study would be to describe clinical faculties of COVID-19 patients admitted to the level 4 COVID medical center and discover their reference to the liver parameters. COVID-19 patients admitted in this degree -4 COVID hospital through the research duration had been classified as mild (Group 1,n=42), moderate (Group 2,n=40) and severe (Group 3,n=35) situations depending on national directions. Serum samples were analyzed using biochemistry autoanalyzer. Serum levels of total and direct bilirubin, Alanine Transaminase (ALT) and Aspartate Transaminase (AST), Alkaline Phosphatase (ALKP), total protein and albumin had been assayed. Clients with higher BMI (Body mass index) had developed better COVID-19 associated problems thus must be admitted either in HDU (Grouknown. Hence, additional research and long term follow up of recovered COVID-19 instances is warranted to understand the pathophysiology and implication of liver injury that develops both in overt and covert kinds during illness.